Your browser doesn't support javascript.
loading
Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE).
Ryu, Min-Hee; Lee, Kyung Hee; Shen, Lin; Yeh, Kun-Huei; Yoo, Changhoon; Hong, Young Seon; Park, Young Iee; Yang, Sung Hyun; Shin, Dong Bok; Zang, Dae Young; Kang, Won Ki; Chung, Ik-Joo; Kim, Yeul Hong; Ryoo, Baek-Yeol; Nam, Byung-Ho; Park, Young Soo; Kang, Yoon-Koo.
Afiliação
  • Ryu MH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Lee KH; Department of Hemato-oncology, Yeungnam University Hospital, Daegu, South Korea.
  • Shen L; Department of Gastrointestinal Medical Oncology, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, China.
  • Yeh KH; Department of Oncology, National Taiwan University Hospital; and Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Yoo C; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Hong YS; Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, South Korea.
  • Park YI; Center for Gastric Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, South Korea.
  • Yang SH; Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, South Korea.
  • Shin DB; Division of Hematology/Oncology, Department of Internal Medicine, Gachon University Gil Hospital, Incheon, South Korea.
  • Zang DY; Division of Hematology-Oncology, Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine, Anyang, South Korea.
  • Kang WK; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School Medicine, Seoul, South Korea.
  • Chung IJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Gwangju, South Korea.
  • Kim YH; Division of Hemato-Oncology, College of Medicine, Korea University, Anam Hospital, Seoul, South Korea.
  • Ryoo BY; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Nam BH; Biometric Research Branch, National Cancer Center, Goyang, Gyeonggi, South Korea.
  • Park YS; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Kang YK; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Cancer Med ; 12(7): 7784-7794, 2023 04.
Article em En | MEDLINE | ID: mdl-36515003
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas Limite: Humans Idioma: En Ano de publicação: 2023
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas Limite: Humans Idioma: En Ano de publicação: 2023